Industry: Pharmaceuticals, Biotechnology
Xencor, Inc. engineers superior biotherapeutics using its proprietary Protein Design Automation® technology platform and is a leader in the field of antibody Fc engineering to significantly improve antibody potency. The company is internally advancing both XProÔ protein therapeutic candidates and XmAbÔ antibody drug candidates optimized for activity against biologically validated targets. Xencor’s product development is led by a protein therapeutic drug candidate, XProÔ1595, for the treatment of inflammatory disorders and an antibody candidate, XmAbÔ2513, for the treatment of Hodgkin’s Disease and T-cell ( www.xencor.com )
Xencor , Inc.
111 West Lemon Avenue
Monrovia, California 91016
USA
Tel: (626) 305-5900
Fax: (626) 305-0350